Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Bioventus (BVS) Other Gross PP&E Adjustments (2020 - 2026)

Bioventus filings provide 6 years of Other Gross PP&E Adjustments readings, the most recent being $60.4 million for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments fell 1.66% to $60.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $60.4 million, a 1.66% decrease, with the full-year FY2025 number at $60.4 million, down 1.66% from a year prior.
  • Other Gross PP&E Adjustments hit $60.4 million in Q4 2025 for Bioventus, up from -$11.6 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $62.8 million in Q4 2023 to a low of -$38.1 million in Q2 2023.
  • Median Other Gross PP&E Adjustments over the past 5 years was -$12.9 million (2024), compared with a mean of $5.6 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: soared 348.61% in 2024 and later crashed 128.29% in 2025.
  • Bioventus' Other Gross PP&E Adjustments stood at $28.9 million in 2021, then skyrocketed by 43.81% to $41.6 million in 2022, then surged by 51.18% to $62.8 million in 2023, then fell by 2.18% to $61.5 million in 2024, then decreased by 1.66% to $60.4 million in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were $60.4 million (Q4 2025), -$11.6 million (Q3 2025), and -$12.0 million (Q2 2025) per Business Quant data.